Using computer learning to match people with the best antidepressant
Machine learning to personalize antidepressant treatment
This project uses computer learning to help match people starting antidepressants with the medication most likely to help them.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Kaiser Foundation Research Institute NIH-funded |
| Lab location | 1 site (Oakland, UNITED STATES) |
| Project ID | NIH-11403758 on NIH RePORTER |
What this research studies
Researchers will analyze large sets of medical records from many patients who have taken antidepressants and use machine-learning tools to find patterns linked to success with particular drugs. They will combine information like symptoms, diagnoses, past treatments, doses, side effects, demographics, and available biological markers to train prediction models. The team will work to separate overall chances of getting better from benefits tied to specific medications so predictions are more useful. The work draws on harmonized data from the Mental Health Research Network and Kaiser to increase sample size and reliability.
Who could benefit from this research
Good fit: Ideal candidates are people beginning a new antidepressant whose electronic health records are included in participating health systems.
Not a fit: People without records in the participating systems, those seeking only non-medication treatments, or people with very unusual or complex medical histories may not benefit directly.
Why it matters
Potential benefit: If successful, this could help people get the right antidepressant sooner, reducing months of trial-and-error, discouragement, and dropout.
How similar studies have performed: Previous studies have been small and mixed, so this larger, data-driven machine-learning approach is promising but not yet proven in routine care.
Where this research is happening
Oakland, UNITED STATES
- Kaiser Foundation Research Institute — Oakland, United States (Active)
Researchers
- Principal investigator: Simon, Gregory E. — Kaiser Foundation Research Institute
- Study coordinator: Simon, Gregory E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.